A more recent study shows that dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes [45] which is also related to the ASM transportation by lysosomal exocytosis and fusion to cellular membrane. The gene discussed is SMPD1; the disease is type 2 diabetes mellitus.